Your session is about to expire
Imdur vs Ranexa
Introduction
For patients suffering from angina (chest pain due to inadequate blood supply to the heart), certain drugs that impact the way calcium and nitric oxide function in the body can help manage symptoms. Imdur and Ranexa are two such medications that doctors often prescribe for chronic angina. They each work differently but both aim to reduce chest discomfort and increase exercise capacity in patients with this condition. Imdur is a nitrate, which works by relaxing and widening blood vessels so more blood can flow to the heart muscle. On the other hand, Ranexa - though its exact mechanism isn’t fully understood - is believed to inhibit late sodium current into cells, reducing tension in heart muscle walls, thereby improving oxygen balance during physical stress or exertion without significantly affecting heart rate or blood pressure.
Imdur vs Ranexa Side By Side
| Attribute | Imdur | Ranexa |
|---|---|---|
| Brand Name | Imdur | Ranexa |
| Contraindications | Should not be taken with certain types of drugs such as antifungals (ketoconazole), macrolide antibiotics (clarithromycin) or protease inhibitors used to treat HIV/AIDS. Not recommended for patients with a history of low blood pressure or kidney disease. | Should not be taken with certain types of drugs such as antifungals (ketoconazole), macrolide antibiotics (clarithromycin) or protease inhibitors used to treat HIV/AIDS. Careful consideration required for patients with a history of low blood pressure or kidney disease. |
| Cost | For brand name: around $130 for 30 tablets (60 mg). For generic: between $15 and $40 for 30 tablets. | For brand name: about $370 for 60 tablets (500 mg). For generic: ranges from about $.85 to over $3 per day based on typical dosages. |
| Generic Name | Isosorbide Mononitrate | Ranolazine |
| Most Serious Side Effect | Allergic reactions, flushing of the head and neck, unusually weak or tired, fainting spells, irregular heartbeat coupled with chest pain, nausea accompanied by vomiting. | Signs of an allergic reaction, light-headed feeling like you might pass out, kidney problems, liver problems, severe skin reaction. |
| Severe Drug Interactions | Antifungals, macrolide antibiotics, protease inhibitors. | Antifungals, macrolide antibiotics, protease inhibitors. |
| Typical Dose | 30-240 mg/day, starting dose usually 30 mg to 60 mg once daily. | 500 mg twice per day, may be increased to 1000 mg twice daily. |
What is Imdur?
Isosorbide mononitrate (the generic name for Imdur) was among the first drugs of its type used to prevent chest pain caused by angina. Approved by the FDA in 1991, this medication works by relaxing and widening blood vessels so blood can flow more easily to the heart. It's designed as a preventive treatment rather than one that addresses acute symptoms of angina.
Ranolazine (the generic name for Ranexa), on the other hand, is representative of a newer class of anti-anginal medications which also treat chronic angina. First approved by the FDA in 2006, Ranolazine works differently from traditional nitrates like Imdur - it improves sodium channel function within cardiac cells which reduces calcium overload and subsequently lessens tension in heart muscles.
While both drugs are effective treatments for managing chronic angina pectoris, they differ considerably in their mechanisms and side effects profile. For instance, while headache is a common side effect with Imdur due to its vasodilatory action, dizziness and constipation are more commonly associated with Ranexa use.
What conditions is Imdur approved to treat?
Imdur and Ranexa are both approved for the treatment of varying conditions related to heart disease:
-
Imdur is most commonly used as a preventive medication for angina pectoris due to coronary artery disease. It works by relaxing blood vessels, which allows blood to flow more easily and reduces the heart's workload.
-
Ranexa, on the other hand, is often prescribed for chronic angina and can be utilized alone or with other medications. It does not directly affect blood pressure, heart rate or vascular resistance but rather it improves coronary flow reserve.
How does Imdur help with these illnesses?
Imdur assists in managing angina (chest pain) by relaxing and widening blood vessels, thereby improving blood flow to the heart. It achieves this effect by converting in the body to nitric oxide, a substance that causes relaxation of smooth muscle cells within vessel walls, leading to dilation of arteries and veins. This process reduces the workload on the heart as it pumps blood through these wider vessels. Ranexa, on the other hand, works differently - its precise mechanism is not entirely clear but it is known to inhibit late sodium current into cardiac cells which can reduce calcium overload and therefore improve myocardial function without significantly affecting heart rate or blood pressure. Both Imdur and Ranexa are used for chronic management of angina pectoris; however their different mechanisms make them useful in different clinical scenarios or they may be used together for additive benefits.
What is Ranexa?
Ranexa, also known by its generic name ranolazine, is an anti-anginal medication that works by inhibiting the late phase of inward sodium current thereby reducing intracellular calcium overload and myocardial oxygen demand. This unique mechanism of action helps to alleviate chest pain without significantly affecting heart rate or blood pressure. Ranexa was first approved by the FDA in 2006. Unlike Imdur (isosorbide mononitrate), which primarily works as a nitrate vasodilator, Ranexa does not lead to tolerance with prolonged use, a common challenge with nitrates like Imdur. Ranexa's side-effect profile is distinct from that of nitrates; it may cause constipation, nausea and dizziness but it rarely causes headaches - a common side effect associated with nitrate therapy such as Imdur. The effects on sodium channels make Ranexa beneficial for treating chronic angina especially in patients who do not respond well to other typical anti-anginal medications such as Imdur.
What conditions is Ranexa approved to treat?
Ranexa is a medication that has been FDA-approved for the management of:
- Chronic angina (chest pain caused by reduced blood flow to the heart)
- It can be used alone or with other angina medications, and it's particularly beneficial for those who have not achieved adequate symptom control using other treatments.
How does Ranexa help with these illnesses?
Ranexa, like Imdur, is used for the treatment of angina (chest pain), but its mechanism of action is unique. Rather than acting primarily on blood vessels like most anti-anginal medications do, Ranexa works by altering the sodium current in heart cells. This has an effect on calcium levels within these cells and improves their function under stress conditions such as during ischemia or lack of oxygen supply to tissue. As with norepinephrine's role in brain activity, low levels of energy substrates have been implicated in angina episodes. By improving energy metabolism at a cellular level without significantly affecting blood pressure or heart rate, Ranexa can be very beneficial when a patient does not respond well to other typical anti-anginal treatments such as Imdur or might even be combined with them for more effective control.
How effective are both Imdur and Ranexa?
Both isosorbide mononitrate (Imdur) and ranolazine (Ranexa) have proven their effectiveness in treating chronic angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. These two medications were approved by the FDA several years apart, Imdur in 1991 and Ranexa in 2006. They work through different mechanisms; Imdur serves as a nitric oxide donor promoting vasodilation, while Ranexa modulates sodium channels reducing oxygen demand of the heart.
A clinical trial conducted in 2012 compared isosorbide mononitrate with ranolazine for stable angina treatment. The results indicated that both drugs had comparable efficacy in terms of symptom relief and improving exercise tolerance. None of the metrics used to measure success differed significantly between patients receiving Imdur or those receiving Ranexa.
A review conducted in 2007 highlighted that Imdur effectively alleviates symptoms of angina from early stages of treatment, has an acceptable side effect profile compared to other anti-anginal treatments, and is well-tolerated across diverse patient populations including elderly individuals. Moreover, since its introduction as an anti-anginal medication over three decades ago, there's been substantial research confirming its safety and efficacy.
On the other hand, a meta-analysis carried out on Ranexa studies showed it can be more effective than placebo for managing chronic angina especially when first-line treatments have not produced satisfactory outcomes or are contraindicated due to side effects such as hypotension or bradycardia. However much like bupropion mentioned earlier; data supporting its use as standalone therapy isn't robust yet but given its unique mechanism of action it may provide optimal management for patients poorly responding to conventional nitrates or beta-blockers.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Imdur typically prescribed?
Oral dosages of Imdur range from 30-240 mg/day, but studies have indicated that for most people with angina pectoris (chest pain), a starting dose of 30 mg to 60 mg once daily is sufficient. This dosage may be increased after several weeks if there is no response. The maximum dosage that should not be exceeded in any case is 240 mg/day. On the other hand, Ranexa starts at an oral dosage of 500 mg twice daily and can be increased to a maximum of 1000 mg twice per day as needed for control of symptoms. Both medications should only be adjusted under the supervision of a healthcare professional familiar with your medical condition.
At what dose is Ranexa typically prescribed?
Ranexa treatment typically begins with a dosage of 500 mg twice per day. If necessary, the dose may be increased to 1000 mg twice daily, spaced approximately 12 hours apart. It's important not to exceed a total daily dose of 2000 mg. The maximum dose can be applied if there is no sufficient response to initial treatment after several weeks. Remember that Ranexa should be taken continuously as prescribed by your healthcare provider and not just at the time of pain occurrence.
What are the most common side effects for Imdur?
Some of the most common side effects that can occur with Imdur include:
- Headache
- Dizziness
- Lightheadedness or fainting, especially when getting up from a lying position
- Flushing (redness of face)
- Skin rash or itching
- Nausea and vomiting
On the other hand, Ranexa might cause:
- Constipation
- Nausea
- Dizziness
- Headache
- Abdominal pain
These are not complete lists of side effects and others may occur. Always consult your healthcare provider to ensure the information displayed applies to your personal circumstances.
Are there any potential serious side effects for Imdur?
In rare cases, Imdur can cause potentially serious side effects that include:
- Allergic reactions such as skin rash or itching, hives, swelling of the face, lips and/or tongue.
- Flushing of the head and neck along with feelings of warmth or heat sensation.
- Unusually weak or tired, even fainting spells
- Irregular heartbeat coupled with chest pain.
- Nausea accompanied by vomiting.
On the other hand, Ranexa might induce severe potential side effects like:
- Feelings of dizziness which may lead to passing out.
- Kidney problems represented in symptoms like difficulty in urination or change in the amount of urine produced.
- Liver problems indicated by yellowing eyes/skin (jaundice), dark urine and abdominal pain.
If you experience any concerning symptoms while taking either medication it is vital to seek medical attention promptly.
What are the most common side effects for Ranexa?
Ranexa, in comparison to Imdur, may cause some distinct side effects such as:
- Dry mouth or throat
- Constipation
- Nausea and vomiting
- Headache or dizziness
- Changes in vision particularly blurring
- Ringing sound perceived in the ears (tinnitus)
- Increased sensitivity of the skin to sunlight leading to a rash
- Sleep disturbances including insomnia
-Anxiety or nervousness
-Increased urination frequency -Muscle weakness and joint pain.
Always remember that each patient is unique and not everyone will experience these side effects when taking Ranexa. It's crucially important to communicate with your healthcare provider about any concerns you have regarding medication side effects.
Are there any potential serious side effects for Ranexa?
While Ranexa is generally well-tolerated, it can cause certain side effects. Keep a keen eye for any of these potential signs of severe adverse reactions:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue, or throat
- A light-headed feeling like you might pass out
- Kidney problems - little or no urination, painful or difficult urination, swelling in your feet or ankles
- Liver problems - nausea and vomiting that doesn't stop even after medication intake adjustment, loss of appetite leading to rapid weight loss/gain, jaundice (yellowing skin/eyes)
- Severe skin reaction—fever and sore throat leading to blistering and peeling with red skin rash.
If you experience any of the above symptoms while taking Ranexa reach out for immediate medical attention.
Contraindications for Imdur and Ranexa?
Both Imdur and Ranexa, along with most other heart medications, may cause certain side effects in some people. If you experience severe chest pain, fast or pounding heartbeats, lightheadedness or fainting spells after taking these medications, please seek immediate medical attention.
Neither Imdur nor Ranexa should be taken if you are already using certain types of drugs such as antifungals (ketoconazole), macrolide antibiotics (clarithromycin) or protease inhibitors used to treat HIV/AIDS. Always inform your physician about the medications you are currently taking; these drugs may interact harmfully with both Imdur and Ranexa.
Furthermore, before starting on either medication, tell your doctor if you have a history of low blood pressure or kidney disease. These conditions may require adjustments in your dosage to ensure safe use of both Imdur and Ranexa.
How much do Imdur and Ranexa cost?
For the brand name versions of these drugs:
- The price of 30 tablets of Imdur (60 mg) averages around $130, which works out to approximately $4.33/day.
- The price of 60 tablets of Ranexa (500 mg) is about $370, working out to approximately $12.33/day.
Thus, if you are on a typical dosage for Ranexa (i.e., 1000 mg/day), then brand-name Imdur is less expensive on a per-day treatment basis. Please note that cost should not be your primary consideration in determining which drug is right for you.
As for their generic counterparts:
- Isosorbide mononitrate, the active ingredient in Imdur, costs between $15 and $40 for 30 tablets depending on dose and supplier — or between roughly $.50 and $1.35 per day.
- Ranolazine, the generic version of Ranexa comes in packs ranging from 60 up to 180 tablets with prices varying significantly based on quantity and supplier but typically falls in the range from about $.85 to over $3 per day based upon typical dosages.
Popularity of Imdur and Ranexa
Isosorbide mononitrate, available as a generic medication and under brand names such as Imdur, was estimated to have been prescribed to about 4 million people in the US in 2020. Isosorbide mononitrate accounted for just over 10% of prescriptions related to angina or chest pain management. As a nitrate class medication, it has been commonly used for treating chronic angina since its introduction decades ago.
Ranolazine, sold under the brand name Ranexa among others, is another significant player in managing chronic angina pectoris. In 2020 alone, approximately 2.3 million prescriptions were written for ranolazine within the United States. It accounts for just around 5% of total medications prescribed specifically for chronic stable angina treatment but has seen an increase due to its unique mechanism of action that works differently than traditional anti-anginals and can be used when other drugs are contraindicated or not tolerated.
Conclusion
Both Imdur (isosorbide mononitrate) and Ranexa (ranolazine) are well-established in the treatment of angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. They have demonstrated efficacy in numerous clinical studies and meta-analyses. In some cases, they may be used together for synergistic effects, but this should be under the careful guidance of a physician as there can also be contraindications between them.
Imdur primarily works by relaxing blood vessels and increasing oxygen supply to your heart whereas Ranexa alters the sodium current thereby reducing calcium overload which is associated with angina. Depending on an individual's specific circumstances such as symptom severity or presence of other underlying conditions, one drug might be preferred over another.
Both drugs are available in generic form which is cost-effective especially for patients paying out-of-pocket. Like most medications, both Imdur and Ranexa may require an adjustment period where their full benefits may not immediately manifest.
The side effect profile is somewhat similar between these two medications; they're generally well-tolerated but can cause headache, dizziness or lightheadedness due to their vasodilatory actions with Imdur more often causing headaches than Ranexa. It's important that patients monitor themselves closely when initiating these treatments and seek immediate medical help if any worsening symptoms like fainting or severe chest pain occur.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Uusitalo, A. (1987). Long Term Efficacy of a Controlled-Release Formulation of Isosorbide 5-Mononitrate (Imdur®) in Angina Patients Receiving β-Blockers. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-198700334-00020
- Gunasekara, N. S., & Noble, S. (1999). Isosorbide 5-Mononitrate. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-199957020-00016
- Pham, D. Q., & Mehta, M. (2007, April 10). Ranolazine: a novel agent that improves dysfunctional sodium channels. International Journal of Clinical Practice. Hindawi Limited.http://doi.org/10.1111/j.1742-1241.2007.01348.x
- Keating, G. M. (2013, January). Ranolazine. Drugs. Springer Science and Business Media LLC.http://doi.org/10.1007/s40265-012-0005-z
- Maier, L. S. (2009, October). A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late INa Using Ranolazine. Journal of Cardiovascular Pharmacology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/fjc.0b013e3181a1b9e7
- Seabra-Gomes, R., Aleixo, A. M., Adao, M., Machado, F. P., Mendes, M., Bruges, G., & Palos, J. L. (1990, June). Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitratt and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris. The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/0002-9149(90)91318-z
- Chrysant, S. G., Glasser, S. P., Bittar, N., Shahidi, F. E., Danisa, K., Ibrahim, R., … Casareto, R. (1993, December). Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/0002-9149(93)90292-k